Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Piper Sandler

Galmed Pharmaceuticals Ltd.
Start price
€0.37
20.05.24 / 50%
Target price
€73.65
20.05.25
Performance (%)
1648.63%
Price
€6.40
19.09.24
Summary
This prediction is currently active. With a performance of 1648.63% the BUY prediction by Piper_Sandler is a big success. This prediction currently runs until 20.05.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Galmed Pharmaceuticals Ltd. - -
iShares Core DAX® -1.114% 3.430%
iShares Nasdaq 100 1.816% 6.911%
iShares Nikkei 225® 2.113% 5.501%
iShares S&P 500 2.038% 5.327%

Comments by Piper_Sandler for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) 1648.63%
Target price 73.648
Change
Ends at 20.05.25

Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $60.00.
Ratings data for GMED provided by MarketBeat

Piper Sandler 
0
Report Share
20.05.24